TransMedics Group, Inc. (TMDX)

TransMedics Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	395.31	201.68	26.08	25.08	20.59
Short-Term Investments	0	0	66.87	101.06	60.6
Cash & Cash Equivalents	395.31	201.68	92.95	126.14	81.19
Cash Growth	96.01%	116.97%	-26.31%	55.37%	291.44%
Receivables	63.58	27.61	5.93	6.86	6.56
Inventory	44.24	20.61	14.86	11.93	11.22
Other Current Assets	7.53	2.4	4.96	1.83	1.04
Total Current Assets	510.65	252.29	118.71	146.77	100
Property, Plant & Equipment	180.49	24.35	15.69	4.75	4.79
Goodwill and Intangibles	14.34	0	0	0	0
Other Long-Term Assets	0.56	0.5	0.5	0.51	0.51
Total Long-Term Assets	195.39	24.85	16.19	5.26	5.3
Total Assets	706.05	277.15	134.89	152.03	105.3
Accounts Payable	12.72	3.34	6.65	1.21	7.25
Deferred Revenue	1.96	0.24	0.25	0.26	0.17
Current Debt	2.04	1.44	0	0	0
Other Current Liabilities	38.22	18.64	16.34	10.41	8.7
Total Current Liabilities	54.93	23.66	23.24	11.88	16.12
Long-Term Debt	513.91	66.11	43.8	34.66	34.15
Other Long-Term Liabilities	0	0	0	1.6	0.39
Total Long-Term Liabilities	513.91	66.11	43.8	36.26	34.54
Total Liabilities	568.85	89.77	67.04	48.14	50.65
Total Debt	515.95	67.56	43.8	34.66	34.15
Debt Growth	663.74%	54.23%	26.38%	1.50%	1.41%
Retained Earnings	-503.71	-478.68	-442.45	-398.23	-369.48
Comprehensive Income	-0.2	-0.23	-0.19	-0.1	-0
Shareholders' Equity	137.2	187.38	67.85	103.89	54.65
Net Cash / Debt	-120.63	134.13	49.15	91.49	47.04
Net Cash / Debt Growth	-	172.89%	-46.27%	94.48%	-
Net Cash Per Share	-3.71	4.54	1.78	3.70	3.31
Working Capital	455.72	228.63	95.47	134.89	83.89
Book Value Per Share	4.22	6.34	2.46	4.21	3.85

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).